Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells

Choline, an organic cation, is one of the biofactors that play an important role in the structure and the function of biological membranes, and it is essential for the synthesis of phospholipids. Choline positron emission tomography-computed tomography (PET/CT) provides useful information for the im...

Full description

Bibliographic Details
Main Authors: Kaho Hirai, Saiichiro Watanabe, Nozomi Nishijima, Kaoru Shibata, Akane Hase, Tsuyoshi Yamanaka, Masato Inazu
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/15/5190
_version_ 1797561662668013568
author Kaho Hirai
Saiichiro Watanabe
Nozomi Nishijima
Kaoru Shibata
Akane Hase
Tsuyoshi Yamanaka
Masato Inazu
author_facet Kaho Hirai
Saiichiro Watanabe
Nozomi Nishijima
Kaoru Shibata
Akane Hase
Tsuyoshi Yamanaka
Masato Inazu
author_sort Kaho Hirai
collection DOAJ
description Choline, an organic cation, is one of the biofactors that play an important role in the structure and the function of biological membranes, and it is essential for the synthesis of phospholipids. Choline positron emission tomography-computed tomography (PET/CT) provides useful information for the imaging diagnosis of cancers, and increased choline accumulation has been identified in a variety of tumors. However, the molecular mechanisms of choline uptake and choline transporters in pancreatic cancer have not been elucidated. Here, we examined molecular and functional analyses of choline transporters in human pancreatic-cancer cell line MIA PaCa-2 and the elucidation of the action mechanism behind the antitumor effect of novel choline-transporter-like protein 1 (CTL1) inhibitors, Amb4269951 and its derivative Amb4269675. CTL1 and CTL2 mRNAs were highly expressed in MIA PaCa-2 cells, and CTL1 and CTL2 proteins were localized in the plasma membrane and the intracellular compartments, respectively. Choline uptake was characterized by Na<sup>+</sup>-independence, a single-uptake mechanism, and inhibition by choline-uptake inhibitor HC-3, similar to the function of CTL1. These results suggest that the uptake of extracellular choline in MIA PaCa-2 cells is mediated by CTL1. Choline deficiency and HC-3 treatment inhibited cell viability and increased caspase 3/7 activity, suggesting that the inhibition of CTL1 function, which is responsible for choline transport, leads to apoptosis-induced cell death. Both Amb4269951 and Amb4269675 inhibited choline uptake and cell viability and increased caspase-3/7 activity. Ceramide, which is increased by inhibiting choline uptake, also inhibited cell survival and increased caspase-3/7 activity. Lastly, both Amb4269951 and Amb4269675 significantly inhibited tumor growth in a mouse-xenograft model without any adverse effects such as weight loss. CTL1 is a target molecule for the treatment of pancreatic cancer, and its inhibitors Amb4269951 and Amb4269675 are novel lead compounds.
first_indexed 2024-03-10T18:18:05Z
format Article
id doaj.art-a40905ec43d5457289d5b0a83eaf7ec2
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T18:18:05Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-a40905ec43d5457289d5b0a83eaf7ec22023-11-20T07:33:59ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-07-012115519010.3390/ijms21155190Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer CellsKaho Hirai0Saiichiro Watanabe1Nozomi Nishijima2Kaoru Shibata3Akane Hase4Tsuyoshi Yamanaka5Masato Inazu6Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanInstitute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanInstitute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanInstitute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanInstitute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanDepartment of Molecular Preventive Medicine, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanInstitute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanCholine, an organic cation, is one of the biofactors that play an important role in the structure and the function of biological membranes, and it is essential for the synthesis of phospholipids. Choline positron emission tomography-computed tomography (PET/CT) provides useful information for the imaging diagnosis of cancers, and increased choline accumulation has been identified in a variety of tumors. However, the molecular mechanisms of choline uptake and choline transporters in pancreatic cancer have not been elucidated. Here, we examined molecular and functional analyses of choline transporters in human pancreatic-cancer cell line MIA PaCa-2 and the elucidation of the action mechanism behind the antitumor effect of novel choline-transporter-like protein 1 (CTL1) inhibitors, Amb4269951 and its derivative Amb4269675. CTL1 and CTL2 mRNAs were highly expressed in MIA PaCa-2 cells, and CTL1 and CTL2 proteins were localized in the plasma membrane and the intracellular compartments, respectively. Choline uptake was characterized by Na<sup>+</sup>-independence, a single-uptake mechanism, and inhibition by choline-uptake inhibitor HC-3, similar to the function of CTL1. These results suggest that the uptake of extracellular choline in MIA PaCa-2 cells is mediated by CTL1. Choline deficiency and HC-3 treatment inhibited cell viability and increased caspase 3/7 activity, suggesting that the inhibition of CTL1 function, which is responsible for choline transport, leads to apoptosis-induced cell death. Both Amb4269951 and Amb4269675 inhibited choline uptake and cell viability and increased caspase-3/7 activity. Ceramide, which is increased by inhibiting choline uptake, also inhibited cell survival and increased caspase-3/7 activity. Lastly, both Amb4269951 and Amb4269675 significantly inhibited tumor growth in a mouse-xenograft model without any adverse effects such as weight loss. CTL1 is a target molecule for the treatment of pancreatic cancer, and its inhibitors Amb4269951 and Amb4269675 are novel lead compounds.https://www.mdpi.com/1422-0067/21/15/5190pancreatic cancertransportercholinecholine transporter-like proteinceramidecaspase
spellingShingle Kaho Hirai
Saiichiro Watanabe
Nozomi Nishijima
Kaoru Shibata
Akane Hase
Tsuyoshi Yamanaka
Masato Inazu
Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells
International Journal of Molecular Sciences
pancreatic cancer
transporter
choline
choline transporter-like protein
ceramide
caspase
title Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells
title_full Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells
title_fullStr Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells
title_full_unstemmed Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells
title_short Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells
title_sort molecular and functional analysis of choline transporters and antitumor effects of choline transporter like protein 1 inhibitors in human pancreatic cancer cells
topic pancreatic cancer
transporter
choline
choline transporter-like protein
ceramide
caspase
url https://www.mdpi.com/1422-0067/21/15/5190
work_keys_str_mv AT kahohirai molecularandfunctionalanalysisofcholinetransportersandantitumoreffectsofcholinetransporterlikeprotein1inhibitorsinhumanpancreaticcancercells
AT saiichirowatanabe molecularandfunctionalanalysisofcholinetransportersandantitumoreffectsofcholinetransporterlikeprotein1inhibitorsinhumanpancreaticcancercells
AT nozominishijima molecularandfunctionalanalysisofcholinetransportersandantitumoreffectsofcholinetransporterlikeprotein1inhibitorsinhumanpancreaticcancercells
AT kaorushibata molecularandfunctionalanalysisofcholinetransportersandantitumoreffectsofcholinetransporterlikeprotein1inhibitorsinhumanpancreaticcancercells
AT akanehase molecularandfunctionalanalysisofcholinetransportersandantitumoreffectsofcholinetransporterlikeprotein1inhibitorsinhumanpancreaticcancercells
AT tsuyoshiyamanaka molecularandfunctionalanalysisofcholinetransportersandantitumoreffectsofcholinetransporterlikeprotein1inhibitorsinhumanpancreaticcancercells
AT masatoinazu molecularandfunctionalanalysisofcholinetransportersandantitumoreffectsofcholinetransporterlikeprotein1inhibitorsinhumanpancreaticcancercells